| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |